Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The future of chemotherapy in malignant brain tumors.

Literature DB >> 3736902

The future of chemotherapy in malignant brain tumors.

Abstract

Malignant brain tumors respond poorly to chemotherapy. This therapeutic resistance is the result of the marked heterogeneity of malignant gliomas in vivo and in vitro. Different factors, as specific markers, DNA distribution curves, morphology, chromosomal constitution, invasiveness and growth characteristics are considered for the understanding of the biology of malignant brain tumors. A better knowledge of this biology should provide new chemotherapeutic strategies.

Entities: Disease

Mesh：

Substances：

Year: 1986 PMID： 3736902 DOI： 10.1007/bf01743050

Source DB: PubMed Journal: Neurosurg Rev ISSN： 0344-5607 Impact factor: 3.042

16 in total

1. The distribution of nuclear DNA from human brain-tumor cells.

Authors: T Hoshino; K Nomura; C B Wilson; K D Knebel; J W Gray
Journal: J Neurosurg Date: 1978-07 Impact factor: 5.115

2. The influence of AZQ on the DNA distribution of human cerebral tumours in short-term culture.

Authors: G Sieben; L Calliauw; P van Oostveldt; H Roels
Journal: Eur J Cancer Clin Oncol Date: 1985-02

3. Heterogeneous response to chemotherapy of human gliomas grown in nude mice and as clones in vitro.

Authors: W R Shapiro; W A Yung; G A Basler; J R Shapiro
Journal: Cancer Treat Rep Date: 1981

4. Vitamin E increases the growth inhibitory and differentiating effects of tumor therapeutic agents on neuroblastoma and glioma cells in culture.

Authors: K N Prasad; J Edwards-Prasad; S Ramanujam; A Sakamoto
Journal: Proc Soc Exp Biol Med Date: 1980-06

Review 5. Review of basic concepts of cell kinetics as applied to brain tumors.

Authors: T Hoshino; C B Wilson
Journal: J Neurosurg Date: 1975-02 Impact factor: 5.115

6. Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group.

Authors:
Journal: J Neurosurg Date: 1981-07 Impact factor: 5.115

7. Human brain in tissue cultures. VI. Presence of glial fibrillary acidic protein in subcultivated human fetal brain cells as demonstrated by immunofluorescent and immunoperoxidase staining.

Authors: D H Gilden; I Molenaar; M Devlin; L Eng; Z Wroblewska
Journal: Acta Neuropathol Date: 1981 Impact factor: 17.088

1. The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study.

Authors: K R von Wild; T H Knocke
Journal: Neurosurg Rev Date: 1991 Impact factor: 3.042

1 in total